By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


SEARCH JOBS








Company News
INSYS Therapeutics Submits NDA For Its New Oral Formulation Of Dronabinol 8/12/2014 3:04:15 PM
INSYS Therapeutics To Report Second Quarter 2014 Results 7/30/2014 11:37:48 AM
INSYS Therapeutics Updates Timing Of NDA For Dronabinol Oral Solution 7/8/2014 6:55:41 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Dravet Syndrome, A Rare Form Of Epilepsy 7/2/2014 11:07:53 AM
INSYS Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance 7/1/2014 11:31:15 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Rare Form Of Epilepsy, Lennox-Gastaut Syndrome 6/25/2014 11:29:53 AM
INSYS Therapeutics To Present At 9th Annual JMP Securities Healthcare Conference 6/11/2014 9:33:57 AM
INSYS Therapeutics Submits Drug Master File For Cannabidiol Active Pharmaceutical Ingredient (API) 5/30/2014 9:31:10 AM
INSYS Therapeutics To Present At Upcoming Conferences In June 5/22/2014 8:59:03 AM
INSYS Therapeutics Reports First Quarter 2014 Results 5/13/2014 10:08:12 AM
12345
//-->